nodes	percent_of_prediction	percent_of_DWPC	metapath
Epoprostenol—P2RY12—P2Y receptors—P2RY11—narcolepsy	0.116	0.116	CbGpPWpGaD
Epoprostenol—P2RY12—Nucleotide-like (purinergic) receptors—P2RY11—narcolepsy	0.0924	0.0924	CbGpPWpGaD
Epoprostenol—PTGIR—G alpha (s) signalling events—P2RY11—narcolepsy	0.0165	0.0165	CbGpPWpGaD
Epoprostenol—PTGER1—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0123	0.0123	CbGpPWpGaD
Epoprostenol—PTGER1—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0123	0.0123	CbGpPWpGaD
Epoprostenol—PTGER1—G alpha (q) signalling events—P2RY11—narcolepsy	0.0119	0.0119	CbGpPWpGaD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.011	0.011	CbGpPWpGaD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.011	0.011	CbGpPWpGaD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.0106	0.0106	CbGpPWpGaD
Epoprostenol—P2RY12—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0104	0.0104	CbGpPWpGaD
Epoprostenol—P2RY12—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0104	0.0104	CbGpPWpGaD
Epoprostenol—PTGER1—G alpha (q) signalling events—HCRT—narcolepsy	0.0101	0.0101	CbGpPWpGaD
Epoprostenol—P2RY12—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.01	0.01	CbGpPWpGaD
Epoprostenol—PTGIR—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00953	0.00953	CbGpPWpGaD
Epoprostenol—PTGER1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00953	0.00953	CbGpPWpGaD
Epoprostenol—PTGIR—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00953	0.00953	CbGpPWpGaD
Epoprostenol—PTGER1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00953	0.00953	CbGpPWpGaD
Epoprostenol—PTGIR—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0092	0.0092	CbGpPWpGaD
Epoprostenol—PTGER1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0092	0.0092	CbGpPWpGaD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00905	0.00905	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00887	0.00887	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00887	0.00887	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00856	0.00856	CbGpPWpGaD
Epoprostenol—P2RY12—G alpha (i) signalling events—PENK—narcolepsy	0.00816	0.00816	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00816	0.00816	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00816	0.00816	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00816	0.00816	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00816	0.00816	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00788	0.00788	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00788	0.00788	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00785	0.00785	CbGpPWpGaD
Epoprostenol—PTGIR—G alpha (s) signalling events—NPS—narcolepsy	0.00774	0.00774	CbGpPWpGaD
Epoprostenol—PTGER1—G alpha (q) signalling events—TRH—narcolepsy	0.00767	0.00767	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00728	0.00728	CbGpPWpGaD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00686	0.00686	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—HCRTR2—narcolepsy	0.00675	0.00675	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—HCRTR1—narcolepsy	0.00675	0.00675	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0067	0.0067	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0067	0.0067	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—P2RY11—narcolepsy	0.00652	0.00652	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00649	0.00649	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—HCRTR1—narcolepsy	0.00622	0.00622	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—HCRTR2—narcolepsy	0.00622	0.00622	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—HCRTR2—narcolepsy	0.00622	0.00622	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—HCRTR1—narcolepsy	0.00622	0.00622	CbGpPWpGaD
Epoprostenol—P2RY12—G alpha (i) signalling events—HRH3—narcolepsy	0.00609	0.00609	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—P2RY11—narcolepsy	0.006	0.006	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—P2RY11—narcolepsy	0.006	0.006	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00597	0.00597	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00597	0.00597	CbGpPWpGaD
Epoprostenol—P2RY12—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00565	0.00565	CbGpPWpGaD
Epoprostenol—PTGER1—G alpha (q) signalling events—TAC1—narcolepsy	0.00557	0.00557	CbGpPWpGaD
Epoprostenol—PTGER1—G alpha (q) signalling events—NPS—narcolepsy	0.00557	0.00557	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—HCRT—narcolepsy	0.00555	0.00555	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00552	0.00552	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00534	0.00534	CbGpPWpGaD
Epoprostenol—PTGIR—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.0052	0.0052	CbGpPWpGaD
Epoprostenol—PTGER1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.0052	0.0052	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—HCRT—narcolepsy	0.0051	0.0051	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—HCRT—narcolepsy	0.0051	0.0051	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00508	0.00508	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00508	0.00508	CbGpPWpGaD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00498	0.00498	CbGpPWpGaD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00498	0.00498	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—PENK—narcolepsy	0.00494	0.00494	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00484	0.00484	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—PENK—narcolepsy	0.00455	0.00455	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—PENK—narcolepsy	0.00455	0.00455	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00445	0.00445	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00445	0.00445	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—TRH—narcolepsy	0.0042	0.0042	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00401	0.00401	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00401	0.00401	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—TRH—narcolepsy	0.00387	0.00387	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—TRH—narcolepsy	0.00387	0.00387	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—HCRTR2—narcolepsy	0.00382	0.00382	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—HCRTR1—narcolepsy	0.00382	0.00382	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00369	0.00369	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00369	0.00369	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00369	0.00369	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00369	0.00369	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—P2RY11—narcolepsy	0.00369	0.00369	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—HRH3—narcolepsy	0.00369	0.00369	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—HCRTR1—narcolepsy	0.00351	0.00351	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00351	0.00351	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—HCRTR2—narcolepsy	0.00351	0.00351	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00351	0.00351	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—CHKB—narcolepsy	0.0035	0.0035	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—HCRTR2—narcolepsy	0.00347	0.00347	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—HCRTR1—narcolepsy	0.00347	0.00347	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—P2RY11—narcolepsy	0.00339	0.00339	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—P2RY11—narcolepsy	0.00339	0.00339	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—HRH3—narcolepsy	0.00339	0.00339	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—HRH3—narcolepsy	0.00339	0.00339	CbGpPWpGaD
Epoprostenol—PTGER1—G alpha (q) signalling events—HTR2A—narcolepsy	0.00335	0.00335	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—P2RY11—narcolepsy	0.00335	0.00335	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—HCRTR2—narcolepsy	0.00319	0.00319	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—HCRTR2—narcolepsy	0.00319	0.00319	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—HCRTR1—narcolepsy	0.00319	0.00319	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—HCRTR1—narcolepsy	0.00319	0.00319	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—HCRT—narcolepsy	0.00313	0.00313	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—P2RY11—narcolepsy	0.00308	0.00308	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—P2RY11—narcolepsy	0.00308	0.00308	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—TAC1—narcolepsy	0.00305	0.00305	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—NPS—narcolepsy	0.00305	0.00305	CbGpPWpGaD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.003	0.003	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—HCRT—narcolepsy	0.00288	0.00288	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—HCRT—narcolepsy	0.00288	0.00288	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—HCRT—narcolepsy	0.00285	0.00285	CbGpPWpGaD
Epoprostenol—P2RY12—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00282	0.00282	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—TAC1—narcolepsy	0.00281	0.00281	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—TAC1—narcolepsy	0.00281	0.00281	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—NPS—narcolepsy	0.00281	0.00281	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—NPS—narcolepsy	0.00281	0.00281	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—PENK—narcolepsy	0.00279	0.00279	CbGpPWpGaD
Epoprostenol—PTGIS—Adipogenesis—TNF—narcolepsy	0.00263	0.00263	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—HCRT—narcolepsy	0.00262	0.00262	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—HCRT—narcolepsy	0.00262	0.00262	CbGpPWpGaD
Epoprostenol—PTGIR—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00259	0.00259	CbGpPWpGaD
Epoprostenol—PTGER1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00259	0.00259	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—PENK—narcolepsy	0.00257	0.00257	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—PENK—narcolepsy	0.00257	0.00257	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—PENK—narcolepsy	0.00254	0.00254	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00241	0.00241	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—CPT1B—narcolepsy	0.00238	0.00238	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—TRH—narcolepsy	0.00238	0.00238	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—PENK—narcolepsy	0.00233	0.00233	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—PENK—narcolepsy	0.00233	0.00233	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00222	0.00222	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00222	0.00222	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—TRH—narcolepsy	0.00219	0.00219	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—TRH—narcolepsy	0.00219	0.00219	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—TRH—narcolepsy	0.00216	0.00216	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—HRH3—narcolepsy	0.00208	0.00208	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—HCRTR1—narcolepsy	0.00205	0.00205	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—HCRTR2—narcolepsy	0.00205	0.00205	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—TRH—narcolepsy	0.00198	0.00198	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—TRH—narcolepsy	0.00198	0.00198	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—P2RY11—narcolepsy	0.00198	0.00198	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—HRH3—narcolepsy	0.00192	0.00192	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—HRH3—narcolepsy	0.00192	0.00192	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—HRH3—narcolepsy	0.00189	0.00189	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—HCRTR1—narcolepsy	0.00188	0.00188	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—HCRTR2—narcolepsy	0.00188	0.00188	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—HCRTR1—narcolepsy	0.00188	0.00188	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—HCRTR2—narcolepsy	0.00188	0.00188	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—HTR2A—narcolepsy	0.00184	0.00184	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—P2RY11—narcolepsy	0.00182	0.00182	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—P2RY11—narcolepsy	0.00182	0.00182	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—HRH3—narcolepsy	0.00174	0.00174	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—HRH3—narcolepsy	0.00174	0.00174	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—TAC1—narcolepsy	0.00173	0.00173	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—NPS—narcolepsy	0.00173	0.00173	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—HTR2A—narcolepsy	0.00169	0.00169	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—HTR2A—narcolepsy	0.00169	0.00169	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—HCRT—narcolepsy	0.00168	0.00168	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—TAC1—narcolepsy	0.00159	0.00159	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—NPS—narcolepsy	0.00159	0.00159	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—NPS—narcolepsy	0.00159	0.00159	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—TAC1—narcolepsy	0.00159	0.00159	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—TAC1—narcolepsy	0.00157	0.00157	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—NPS—narcolepsy	0.00157	0.00157	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—HCRT—narcolepsy	0.00155	0.00155	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—HCRT—narcolepsy	0.00155	0.00155	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PENK—narcolepsy	0.0015	0.0015	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—TAC1—narcolepsy	0.00144	0.00144	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—NPS—narcolepsy	0.00144	0.00144	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—NPS—narcolepsy	0.00144	0.00144	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—TAC1—narcolepsy	0.00144	0.00144	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PENK—narcolepsy	0.00138	0.00138	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PENK—narcolepsy	0.00138	0.00138	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TRH—narcolepsy	0.00127	0.00127	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00127	0.00127	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TRH—narcolepsy	0.00117	0.00117	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TRH—narcolepsy	0.00117	0.00117	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—HRH3—narcolepsy	0.00112	0.00112	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—HTR2A—narcolepsy	0.00104	0.00104	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—HRH3—narcolepsy	0.00103	0.00103	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—HRH3—narcolepsy	0.00103	0.00103	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—HTR2A—narcolepsy	0.000955	0.000955	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—HTR2A—narcolepsy	0.000955	0.000955	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—HTR2A—narcolepsy	0.000943	0.000943	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NPS—narcolepsy	0.000926	0.000926	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TAC1—narcolepsy	0.000926	0.000926	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—HTR2A—narcolepsy	0.000868	0.000868	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—HTR2A—narcolepsy	0.000868	0.000868	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000862	0.000862	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NPS—narcolepsy	0.000852	0.000852	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TAC1—narcolepsy	0.000852	0.000852	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TAC1—narcolepsy	0.000852	0.000852	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NPS—narcolepsy	0.000852	0.000852	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CHKB—narcolepsy	0.000565	0.000565	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—HTR2A—narcolepsy	0.000557	0.000557	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—HTR2A—narcolepsy	0.000513	0.000513	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—HTR2A—narcolepsy	0.000513	0.000513	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CPT1B—narcolepsy	0.000384	0.000384	CbGpPWpGaD
